Total medical devices industry M&A deals worth $831.84m were announced in the US in February 2021, with Veracyte’s $600m acquisition of Decipher Biosciences being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 96.2% over the previous month of $22.04bn and a drop of 87.9% when compared with the last 12-month average of $6.9bn.

The US held a 96.52% share of the global medical devices industry M&A deal value that totalled $861.84m in February 2021.

In terms of M&A deal activity, the US recorded 28 deals during February 2021, marking a decrease of 12.50% over the previous month and a rise of 33.33% over the 12-month average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

US medical devices industry M&A deals in February 2021: Top deals

The top five medical devices industry M&A deals accounted for 99.6% of the overall value during February 2021.

The combined value of the top five medical devices M&A deals stood at $828.34m, against the overall value of $831.84m recorded for the month.

The top five medical devices industry M&A deals of February 2021 tracked by GlobalData were:

1) Veracyte’s $600m acquisition of Decipher Biosciences

2) The $150m acquisition of Simplify Medical by NuVasive

3) Mind Medicine MindMed’ $32.66m acquisition of HealthMode.

4) The $23.68m acquisition of Chronix Biomedical by OncoCyte

5) Volpara Solutions’ acquisition of CRA Health for $22m.